» Articles » PMID: 24308969

Bilirubin Mediated Oxidative Stress Involves Antioxidant Response Activation Via Nrf2 Pathway

Overview
Journal Cell Signal
Date 2013 Dec 7
PMID 24308969
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Unconjugated bilirubin (UCB) is responsible for neonatal jaundice and high level of free bilirubin (Bf) can lead to kernicterus. Previous studies suggest that oxidative stress is a critical component of UCB-induced neurotoxicity. The Nrf2 pathway is a powerful sensor for cellular redox state and is activated directly by oxidative stress and/or indirectly by stress response protein kinases. Activated Nrf2 translocates to nucleus, binds to Antioxidant Response Element (ARE), and enhances the up-regulation of cytoprotective genes that mediate cell survival. The aim of the present study was to investigate the role of Nrf2 pathway in cell response to bilirubin mediated oxidative stress in the neuroblastoma SH-SY5Y cell line. Cells exposed to a toxic concentration of UCB (140 nM Bf) showed an increased intracellular ROS levels and enhanced nuclear accumulation of Nrf2 protein. UCB stimulated transcriptional induction of ARE-GFP reporter gene and induced mRNA expression of multiple antioxidant response genes as: xCT, Gly1, γGCL-m, γGCL-c, HO-1, NQO1, FTH, ME1, and ATF3. Nrf2 siRNA decreased UCB induced mRNA expression of HO1 (75%), NQO1 (54%), and FTH (40%). The Nrf2-related HO-1 induction was reduced to 60% in cells pre-treated with antioxidant (NAC) or specific signaling pathway inhibitors for PKC, P38α and MEK1/2 (80, 40 and 25%, respectively). In conclusion, we demonstrated that SH-SY5Y cells undergo an adaptive response against UCB-mediated oxidative stress by activation of multiple antioxidant response, in part through Nrf2 pathway.

Citing Articles

Significance of Malic Enzyme 1 in Cancer: A Review.

Fujiwara-Tani R, Nakashima C, Ohmori H, Fujii K, Luo Y, Sasaki T Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996805 PMC: 11854147. DOI: 10.3390/cimb47020083.


Ferritin Hinders Ferroptosis in Non-Tumorous Diseases: Regulatory Mechanisms and Potential Consequences.

Xie Z, Hou Q, He Y, Xie Y, Mo Q, Wang Z Curr Protein Pept Sci. 2024; 26(2):89-104.

PMID: 39225224 DOI: 10.2174/0113892037315874240826112422.


Atorvastatin inhibits Lipopolysaccharide (LPS)-induced vascular inflammation to protect endothelium by inducing Heme Oxygenase-1 (HO-1) expression.

Luo J, Zhu Q, Huang K, Wen X, Peng Y, Chen G PLoS One. 2024; 19(8):e0308823.

PMID: 39146322 PMC: 11326635. DOI: 10.1371/journal.pone.0308823.


Nrf2-mediated ferroptosis inhibition: a novel approach for managing inflammatory diseases.

Han H, Zhang G, Zhang X, Zhao Q Inflammopharmacology. 2024; 32(5):2961-2986.

PMID: 39126567 DOI: 10.1007/s10787-024-01519-7.


AMPK pathway: an emerging target to control diabetes mellitus and its related complications.

Kakoti B, Alom S, Deka K, Halder R J Diabetes Metab Disord. 2024; 23(1):441-459.

PMID: 38932895 PMC: 11196491. DOI: 10.1007/s40200-024-01420-8.